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Abstract 
Ketamine provides a useful model for studying the physiopathology of schizophrenia as it 
induces and exacerbates schizophrenic symptoms in healthy individuals and patients, 
respectively. However, it remains unclear how ketamine affects neural oscillations across 
frequency bands and the extent to which changes in cortical firing are independent from 
ketamine’s cardiovascular effects. The present study used 1-norm support vector machine (SVM) 
as a classification approach to determine sources of psychophysiological signal, considering both 
EEG and ECG, characterizing primary effects of ketamine administration. EEG and ECG 
recordings of 11 participants were collected before (saline) and after the ketamine (0.5 mg/kg) 
intravenous infusion The 1-norm SVM model built on EEG and ECG in combination 
successfully differentiated the two sessions and identified prominent EEG features associated 
with neuronal oscillation alternation between sessions, which includes beta, delta frequency 
bands from both F3 and F4.  However, SVM models based on EEG or ECG, taken alone, 
performed only slightly above chance. 1-norm SVM models suggest that machine learning 
methods could successfully distinguish saline and ketamine sessions, but only when both EEG 
and ECG single trial data were considered. Our findings show concurrent cardiac and brain 
effects of ketamine that may resemble alterations in the prodromal phase of schizophrenia. 







	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	   1	  
 
1-norm support vector machine on single-trial EEG and ECG data to identify neural oscillatory 
features in the ketamine model for schizophrenia 
Introduction 
Ketamine is commonly used as a dissociative anesthetic. As a noncompetitive N-methyl-
D-aspartate receptor (NMDAR) antagonist, it inhibits glutamate activity and can transiently 
induce psychosis symptoms and cognitive deficits (Javitt & Zukin, 1991; Lahti, Weiler, 
Michaelidis, Parwani, & Tamminga, 2001). Experiments in human and animal subjects show that 
ketamine can induce both positive and negative schizophrenic symptoms. In experiments with 
healthy adults, subjects experience schizophrenic symptoms such as altered sensory perceptions, 
bizarre and impoverished thoughts and speech, impaired attention, and disrupted memory 
(Krystal et al., 1994). Therefore, ketamine infusion offers a useful pharmacological model for 
studying schizophrenia and has led to a paradigm shift from dopaminergic to glutamatergic 
dysfunction.  
             Although the ketamine model has strong explanatory and epistemic values, there have 
been questions about the validity of the ketamine model for schizophrenia. One of the main 
weaknesses of the ketamine model is that neuronal oscillations induced by ketamine do not seem 
to reflect oscillatory abnormalities found in schizophrenia. EEG studies revealed that abnormal 
oscillatory activity in schizophrenia is particularly at the gamma band (30-80 Hz) (Kehrer, 
Maziashvili, Dugladze, & Gloveli, 2008; Roopun et al., 2008; Uhlhaas, 2013; Uhlhaas & Singer, 
2011). Reduced oscillations at gamma band were found in Schizophrenia patients in several 
studies (Kehrer et al., 2008; Roopun et al., 2008; Uhlhass and Singer, 2011), however, increases 
at gamma band were also observed (Bucci, Mucci, Merlotti, Volpe, & Galderisi, 2007). It is 
widely believed that abnormalities in gamma band neuronal oscillation are due to fast-spiking 
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GABAergic interneurons (Gloveli et al., 2005; Hájos et al., 2004), which should be affected by 
ketamine infusion. However, compared with EEG findings in schizophrenia patients, EEG 
studies on ketamine’s effect on neuronal oscillation yielded to diverse, even opposite results. 
Animal studies showed that ketamine does not affect gamma rhythms in neocortex and 
hippocampus (Cunningham et al., 2006; Roopun et al., 2008). Another study on clinical 
population showed that ketamine administration increases the amplitude of the 40 Hz EEG signal 
(Plourde, Baribeau, & Bonhomme, 1997), whereas in schizophrenia patients, the amplitude of 
40Hz EEG signal is instead reduced (Hamm, Gilmore, Picchetti, Sponheim, & Clementz, 2011). 
The gamma band is not the only frequency band with abnormal oscillatory activity in 
schizophrenia. Various abnormalities have been observed in high beta (20-29) band as well. One 
study found that schizophrenic patients with auditory hallucinations show an increase in resting 
beta power in parietal and frontal cortices (Sponheim, Clementz, Iacono, & Beiser, 2000). 
Although some studies found that ketamine has similar effect on beta band oscillations (Lee et 
al., 2006; Mulert, Kirsch, Pascual-Marqui, McCarley, & Spencer, 2011), null results were also 
reported (L. E. Hong et al., 2010). 
One possible explanation of the diverse results from EEG studies is the lack of objectivity 
and reliability in conventional EEG data analysis. First, the analysis of EEG data often involves 
different levels of subjective data preprocessing, such as removing artifacts and selecting event 
time windows, and thus leaving a large portion of the EEG record discarded from further 
analysis.  Also, for group level analysis, conventional method uses averaged waveforms of all 
participants’ time-frequency data. By doing so, we may lose important information since 
individuals’ neural activities generated endogenously are not captured in averaged waveforms. In 
addition, having a priori hypothesis sets limits on potentials findings from the datasets, and may 
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lead to omission of other information the datasets could tell. Finally, the conventional procedure 
of averaging trials can result in a multiple testing errors. The analysis of EEG data usually 
involves univariate mean group comparisons, such as comparing responses between a clinical 
and a control group. Group differences are commonly assessed for several amplitudes and 
latencies at several locations (single electrodes or averages of a set of electrodes), which either 
causes an increase of family-wise type I error due to multiple testing, or a decrease of power if 
the alpha error level is adjusted for multiple testing using Bonferroni or similar methods (Stahl, 
Pickles, Elsabbagh, Johnson, & Team, 2012). Therefore, it would be desirable to have methods 
that improve the statistical power and avoid subjective judgments in the analysis of EEG studies. 
Another potential limitation of traditional EEG data analysis is that the ECG data 
collected along with EEG data ware often neglected and discarded. ECG data can be a good 
reflection of autonomic nervous system (ANS) activities as it produces patterns of oscillation 
that correspond to heart rate variability (HRV) (Heathers, 2014).  HRV is related with 
psychological arousal and is a potential diagnostic and prognostic biomarker in psychiatric 
disorders including depressive disorders (Chang, Chang, Kuo, & Huang, 2015; Munoz et al., 
2015) and bipolar disorder (Eckberg, 2000; Hage et al., 2017).  
            To address these potential problems in EEG data analysis, here we propose applying a 
machine learning classification method on both EEG and ECG data to study the ketamine’s 
effect on neuronal oscillations. Machine learning encompasses a body of approaches that can be 
used for analyzing data through mathematical modeling. Different from traditional null 
hypothesis significance testing method, machine learning method does not set a priori 
hypothesis. Instead, it allows the program to adjust the model accordingly to new information 
until it reaches the optimal result. Machine learning method often employs a multi-fold cross 
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validation method. The validation process allows machine-learning methods to have good 
validity despite relative small sample size. Given these advantages, Machine Learning methods 
have been successfully applied to a variety of fields that deal with high-dimensional data, often 
accompanied by small sample sizes (Bishop, Aamodt-Leeper, Creswell, McGurk, & Skuse, 
2001).  
From a machine learning point of view, identifying ketamine-induced neuronal 
oscillations can be seen as a feature selection problem. Classification algorithm can identify and 
select most significant oscillatory features that can be used to distinguish before and after 
ketamine infusion status. Features we are interested in were defined as neuronal oscillatory 
characteristics, namely the five frequency bands (theta, alpha, beta, delta, and gamma) by neural 
signal measures (EEG and ECG). Support vector machine (SVM) is one of the most commonly 
used classification algorithm. It is a supervised learning algorithm that uses a discriminant 
hyperplane to separate different classes. The advantage of SVM is that it selects a hyperplane 
that maximized the margins. This particular hyperplane maximizes the prediction accuracy of the 
classification of previously unseen cases. However, SVM often produces complex models with 
too many features since it uses the l2 regluarization, in which redundant features are not 
punished. In our analysis, we adopted a novel algorithm based SVM that uses the l1-norm 
regularizer because this regularizer enforces sparsity of the weight vector, meaning that only a 
small portion of the features will be used by the classifier. This strategy, named 1-norm SVM, 
has been proven to be a good combination of avoiding overfitting models and allowing feature 
selection (Zhu, Rosset, Hastie, & Tibshirani, 2003).  
            In our study, we used EEG collected from bilateral frontal, central, and occipital brain, 
along with ECG data, to build classification models and evaluated the performance of the 
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models. We also utilized the 1-norm SVM algorithm to select the most significant features that 
differentiate before and after ketamine infusion status. The selected features are the frequency 
bands that have the most significant neuronal oscillatory changes under ketamine administration.  
Method 
Participants 
Recruitment was done through advertisements on the Internet (e.g. Craiglist) and posters 
in New York State Psychiatric Institute. All recruits went through screening where they received 
a diagnostic interview (Structured Clinical Interview for DSM-5 or Diagnostic Interview for 
Genetic Studies) and a medical exam. During the screening, participant’s blood sample and urine 
sample were collected for a pregnancy test and toxicological screen. The study included 
participants who i) were aged 21 to 45; ii) had no history of recreational ketamine and/or PCP 
use; iii) had no current or past Axis-I psychiatric disorders or history of alcohol/substance abuse; 
(iv) had no first-degree relative with schizophrenia; (v) had no history of violence; (vi) were not 
currently taking psychotropic medication; (vii) had no presence or history of significant medical 
or neurological illness, including high blood pressure (SBP > 140, DBP > 90), cardiac illness, 
head trauma; (viii) were not pregnant, (ix) had no metallic or other material in the body or 
medicinal patch that would preclude safe exposure to MRI and EEG, and (x) had ability to 
provide informed consent. Eleven participants with good quality of EEG data were included in 
analyses (two female and nine male; average age = 28.9, SD= 5.4). The Institutional Review 
Boards of the New York State Psychiatric Institute (NYSPI) and Columbia University Medical 
Center approved this study. 
Experimental Procedures 
            All participants were informed of effects of ketamine and typical reactions after ketamine 
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infusion. And then all participants read and signed informed consent before the experiment 
started. During the experiment, each participant was asked to stay still in an MRI scanner and 
received a sequence of six 13-minute simultaneously EEG and MR scans using a 64-channel 
MRI-compatible EEG recording system (BrainAmp MR plus amplifier; Brain Products HmbH, 
Gilching, Germany). The first scan included quantitative MRI structural imaging for optimal 
segmentation of brain images into gray matter, white matter, and cerebrospinal fluid (CSF). After 
the first scan (baseline), participants started to receive a slow intravenous infusion of saline 
solution with 0.5mg/kg of ketamine hydrochloride (Abbott Laboratories, North Chicago, IL). 
The infusion process was approximately 40 minutes. Both EEG and ECG signals were constantly 
collected prior to, during, and after the ketamine infusion until the end of the experiment. The 
whole sequence of six scans, including time intervals, lasted approximately 90 minutes. Blood 
pressure was monitored and recorded at 5-minute intervals at baseline and throughout the 
ketamine infusion, and at 10-minute intervals following the end of infusion until the end of the 
scan (90 minutes post initiation of ketamine infusion). After the experiment, each participant was 
evaluated by the PI of the study, who is a licensed psychologist and physician, to determine if the 
participant was safe to be discharged from the study without admission for an overnight stay at 
the hospital.   
Measures  
            Neuronal oscillations were recorded using a 64-channel MR-compatible EEG system, 
with direct current BrianAmp MR plus amplifiers (Brain Products HmbH, Gilching, Germany). 
The 64 channels included 62 EEG channels, an electrooculography (EOG) channel and an 
echocardiogram (ECG) channel. EEG signals were referenced to the FCz electrode and grounded 
to the Iz electrode. All signals were hardware-filtered between 0.016 and 250 Hz and sampled at 
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5000Hz.  
Data Analysis  
             In principle, one might leave the method of resolving the best predictor from the entire 
raw ERP record to supervised classification methods. However, in practice, it is usually helpful 
to undertake a preliminary data pre-processing and reduction step to form a set of data features 
(DeBoer, Scott, & Nelson, 2007; Fujioka, Mourad, He, & Trainor, 2011; Hoehl & Wahl, 2012; 
Luck, 2005). 
            EEG signal processing. EEG data was processed offline in BrainVision Analyzer 2.1. 
We first identified extreme values (2000µV -4000µV range) and then used these extreme values 
to create a template for artifact removal, using the Template Drift Compensation method (Allen, 
Josephs, & Turner, 2000; Rosa, Kilner, Blankenburg, Josephs, & Penny, 2010). The DC detrend 
transform was applied to correct for DC trending in EEG data. Other outliers of scalp EEG were 
filtered using low-pass filters (with a cutoff frequency of 100 Hz, slope of 24 dB/octave) and 
high-pass filter (with a cutoff frequency of 0.4 Hz, time constant of 0.398s, slope of 24 
dB/octave) to reduce slow drifts in the signal. In addition, a 60 Hz notch was applied (with a 
bandwidth of 5Hz, symmetric around 60Hz with the edge rise of 24 dB/octave).  
The correction of cardiac artifacts often involves removal of the first several principal 
components that are time locked to QRS waves of the ECG from EEG data. However, this 
method has been criticized for introducing more artifacts in theta and gamma frequency rage. 
Cardioballistic (CB) artifacts were instead automatically marked at the Q component of each 
QRS wave using the following settings of the Cardioballistic Correction Transform (peak 
detection option, semiautomatic mode, pulse rate [bpm]; min-max: 48-110; pulse rate [ms]; 
897.5-352.5, Correlation and Amplitude; Correlation; 0.6, Amplitude; 0.2-0.8, write markers 
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only), without corrections.  
            Time-frequency extraction was applied to single trial data using Morlet continuous 
wavelet transform. The low cutoff of frequency bands was 0.5 Hz, and the high cutoff was 60 
Hz. Time-frequency values were divided into five frequency bands: delta (0.5-4Hz), theta (4-
8Hz), alpha (8-12Hz), beta (14-28Hz), and gamma (30-58Hz) (Chen et al., 2014). For each 
frequency band, trials with outliers that were over two standard deviation from the mean were 
discarded from analysis. Time frequency values from six regions (bilateral frontal, central, 
occipital) and two time windows (before infusion and after infusion) were then exported to 
MATLAB (The MathWorks, Inc., Natick, MA) for further analysis using machine learning 
algorithm.  
            1-norm SVM classification and feature selection. Although the current study is based 
on a relatively small sample (N=11), a large number of EEG and ECG time-frequency data (7810 
trials by five frequencies) were used for analysis. For each of the six regions (bilateral frontal, 
central, and occipital lobes), a 1-norm SVM classification algorithm was used to classify before 
and after ketamine infusion status. The parameter C in the 1-norm SVM was tuned in a 10-fold 
cross-validation process, where the whole dataset was divided into ten equal subsets, and for 
each fold, we used nine of these datasets as training group to develop a classification model, and 
then test the classification model on the remaining one dataset. Receiver operating characteristics 
(ROC) curves were used to evaluate the performance of the classifiers. Specifically, the area 
under the curve (AUC) was reported. We averaged the AUC values over the 10 folds for each 
choice of C in a range from 0.01 to 10e6 with a step size of 10 times. The value of C was 
determined based on the best AUC performance. Then the chosen C value was used to train the 
final classifier using the same SVM model with 10-fold cross-validation. The AUC values were 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	    9	  
reported to evaluate the performance of the final models using the chosen C.  
 
Results   
Using the EEG data alone, classification models produced by 1-norm SVM did not have 
good performances (Table 1). All models had classification accuracy around chance level (AUC 
= 0.5). Using the ECG data alone did not yield meaningful classification model either (AUC = 
0.589). After combing EEG and ECG data together to train the models, better overall 
classification accuracy was achieved. As presented in Table 2 and Figure 1, the SVM model 
successfully differentiated before and after ketamine infusion status based on EEG and ECG 
signals, evident by AUC value of 0.82 for left frontal brain (F3) and AUC value of 0.86 for right 
frontal brain (F4). The 1-norm SVM model also successfully identified prominent features 
associated with neuronal oscillation alternation between ketamine infusion statuses. At left 
frontal region, the 1-norm SVM model identified delta activity, beta activity, and ECG activity 
as the primary features associated with ketamine administration status. At right frontal region, 
the 1-norm SVM model identified delta activity, beta activity, and ECG activity as the primary 
EEG features associated with ketamine administration status (Table 3). Additional features used 
in the models had weightings of .10 or less and were not considered as meaningful for further 
interpretation.  
Power Analysis 
            Machine learning is different from traditional statistical analysis in the way that machine 
learning is more exploratory and does not require a priori hypothesis. However, this does not 
mean that statistical significance level of the present results cannot be calculated.  If we 
understand the analysis using a null hypothesis testing framework, the null hypothesis would be 
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that the 1-norm SVM cannot predict before and after ketamine administration state better than 
chance level. Establishing statistical significance is generally done by determining how 
improbable the observed classification accuracy would be given the null hypothesis is true. The p 
value in this case is the fraction of the sample that is greater than or equal to the accuracy 
actually observed when using the correct labels (Pereira, Mitchell, & Botvinick, 2009).  
             For each SVM model, after testing the model for ten times (10-fold cross-validation), we 
accurately predict 80% cases out of the total test trials. If the null hypothesis was true and the 
classifier was operating at chance level, then we would expect an accuracy of 0.5 at average. 
Thus, we can establish a Bernoulli distribution where for each test trial there is 50% chance to be 
predicted accurately. The probability of having 80% accuracy rate test trials after a 10-fold cross 
validation is C !!" 0.5!0.5!= 0.044. Therefore, in our analysis, the p value is smaller then 0.044.  
A power analysis was conducted using the software package, GPower (Erdfelder, Faul, & 
Buchner, 1996). The sample size of 7810 time-frequency trials was used for the statistical power 
analyses and the α level used was p<0.05. The power analysis revealed the statistical power (1-β) 
of this study is 1, indicating that our finding has a very strong statistical power.  
Discussion 
            It is well known that ketamine induces similar clinical presentations to schizophrenic 
symptoms, but the underlying mechanism remains debatable.  In the present study, we used a 
machine learning based classification algorithm to explore the neural oscillatory changes induced 
by ketamine infusion, aiming to better understand the mechanism of ketamine’s model for 
schizophrenia. One purpose of this study is to test a more objective and exploratory way to 
perform EEG data analysis. The results show that machine learning method not only can solve 
classification problems, but also provide a mean to identify prominent features from multiple 
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regressors. The present analysis utilized ten fold cross validation method in machine learning and 
ensured the result to have considerable statistical power despite the small sample size.   
            To our surprise, neither EEG nor ECG data alone is sufficient for the algorithm to 
generate successful classification models (Table 1). Instead, the algorithm can only differentiate 
before and after ketamine administration statuses by incorporating EEG and ECG data altogether 
(Figure 1). Within this classification model, the features selected by the 1-norm SVM algorithm 
includes bilateral frontal delta band. This is consistent with animal studies. Specifically, findings 
from animal studies showed that ketamine induced decreases in delta power in frontal regions 
(Kargieman, Santana, Mengod, Celada, & Artigas, 2008). Human studies of ketamine’s effect 
also showed decreases in delta (de la Salle et al., 2016; L. E. Hong et al., 2010) in prefrontal 
regions. Our findings of decreased delta at rest are also consistent with what observed in patients 
with schizophrenia (Göder et al., 2006; Keshavan et al., 1998; Sekimoto, Kato, Watanabe, 
Kajimura, & Takahashi, 2011). Delta wave at the frontal regions is considered to be associated 
with the process of information consolidation (Huber, Ghilardi, Massimini, & Tononi, 2004), 
significant changes at delta band might explain working memory deficits elicited by ketamine 
administration as well as cognitive deficits observed in schizophrenic patients.  The features 
selected also include beta band. Beta band’s significance in our 1-norm SVM classification 
model is compatible with previous research evidences of resting beta oscillations in 
schizophrenia patients with auditory hallucinations (Lee et al., 2006; Mulert et al., 2011; Roopun 
et al., 2008). It also maps on the research finding that pathological enhancement of beta-band 
activity is likely to result in deficits in flexible behavioral and cognitive control (Engel & Fries, 
2010) as well as in perception alternation(L. E. Hong, Buchanan, Thaker, Shepard, & 
Summerfelt, 2008). However, past findings focused on the high beta frequency (e.g. 20-29 Hz) 
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while in our analysis we did not further divide the beta frequency band. Further analysis is 
needed to see if it is the high beta band that contributes to the neural oscillatory changes. ECG is 
also a feature selected by the classification model, indicating that cognitive changes observed in 
subjects are accompanied by changes in automatic nervous system (e.g. cardiovascular 
activities).  
            The fact that the classification algorithm can only generate significant result with the 
combination of EEG and ECG data indicated that the interaction of ECG and EEG data plays a 
key role in reflecting ketamine induced physiological changes. The cardiovascular effect of 
ketamine’s data is well studied.	  It is well established that ketamine has a cardiovascular 
stimulation effect (Y. Hong & Henry, 1992), and it may due to the ketamine’s inhibition of 
catecholamine reuptake (Reich & Silvay, 1989). For the past decades, researches on ketamine’s 
model for schizophrenia mainly focused on how ketamine affect the brain directly as an 
NMDAR antagonist and neglected the indirect pathways—the interaction of automatic nervous 
system and brain functions. Certain studies have attempted to explore how cardiovascular 
arousal can affect cognitive functions and found that different HRV can predict different 
performance in a variety of cognitive tasks on executive functioning (Thayer, Hansen, Saus-
Rose, & Johnsen, 2009). Other studies suggest that change in cardiac output can lead changes in 
cerebral blood flow (CBF) (Holcomb, Lahti, Medoff, Weiler, & Tamminga, 2001)(Holcomb et 
al., 2001; La, 2015; Langsjo et al., 2003; Schwedler, Miletich, & Albrecht, 1982), which can be 
associated with both positive and negative schizophrenic symptoms (Bouma & Muizelaar, 1990; 
Liddle et al., 1992). Ketamine’s effect on cognition and perception is probably mediated by more 
mechanisms then we expected. A more comprehensive ketamine model should take its 
cardiovascular effect and CBF effect into consideration.  
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Tables and Figures 
 
 Left Right 
 Frontal Central Occipital Frontal Central Occipital 
AUROC 0.523 0.545 0.554 0.546 0.558 0.499 
 
Table 1. Performance statistics of 1-norm SVM model built on EEG data and ECG data 
separately. AUROC: the Area Under an ROC curve.   
 
 
 Left Right 
 Frontal Central Occipital Frontal Central Occipital 
AUROC 0.820 0.830 0.849 0.860 0.865 0.828 
Table 2. Performance statistics of the models built on EEG and ECG data. AUROC: the Area 




 Left Right 




Beta Beta Beta Beta   
Delta 
 
Delta  Delta  
 
 
ECG  Alpha ECG  Gamma 
 
 
Table 3. Features selected by 1-norm SVM models. Alpha: 8-12 Hz, Beta: 14-29 Hz, Delta 0.5-
5Hz, Gamma: 30-50Hz.  
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Figure 1(a). ROC curve for the classification model generated by using EEG data and ECG data 
from the left frontal area (F3) as training dataset. AUC: area under the curve; ACC: accuracy. 
                         
Figure 1(b). ROC curve for the classification model generated by using EEG data and ECG data 
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